In Vitro Study of Garcinia dulcis (Roxb.) Kurz Leaves Extract against Hepatitis C Virus

Garcinia dulcis Leaves Extract against Hepatitis C Virus


  • Dadan Ramadhan Apriyanto Department of Parasitology, Immunology, and Microbiology, Faculty of Medicine, Universitas Swadaya Gunung Jati
  • Sri Hartati Research Center for Chemistry, Indonesian Institute of Sciences (LIPI), Puspiptek, Serpong 15310, Indonesia
  • Tutik Sri Wahyuni Natural Product Medicine Research and Development, Institute of Tropical Disease, Universitas Airlangga,
  • Maria Inge Lusida Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya 60115, Indonesia



antiviral activity, Garcinia dulcis, hepatitis c virus


Garcinia dulcis is a plant commonly used in traditional medicine in tropical regions. It has anti-bacterial, anti-inflammatory, anti-tumor, and anti-malaria properties. Despite its potential benefits, studies on its effectiveness as an antiviral are limited. This study investigated the antiviral properties of G. dulcis leaf extract against the JFH-1 strain genotype 2a as a treatment for Hepatitis C Virus (HCV). Huh7it-1 cells infected with the HCV genotype 2a strain JFH-1 were used to determine the antiviral effect of methanol extracts of G. dulcis leaves (GD-LE). GD-LE antiviral activity was investigated using a focus-forming assay for anti-HCV and 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay for cytotoxicity. A time-of-addition study of anti-HCV was also performed to determine the mode of action of GD-LE. The results showed that GD-LE inhibited HCV replication with an IC50 of 17.06 µg/mL without giving any toxicity to the cells. The mode-of-action of GD-LE was found to inhibit HCV replication in the co-addition and post-infection stages. These findings suggest that GD-LE could be a promising candidate for anti-HCV treatment. However, further study regarding GD-LE bioactive compound isolation needs to be done to prepare an effective antiviral.


Renau LP, Berenguer M (2018) Introduction to hepatitis C virus infection: Overview and history of hepatitis C virus therapies. Hemodialysis Interna-tional 22: 8–21. doi: 10.1111/hdi.12647.

World Health Organization (2017) Global hepatitis report 2017. Geneva, CC BY-NC-SA 3.0 IGO.

Tong Y, Lavillette D, Li Q, Zhong J (2018) Role of hepatitis C virus envelope glycoprotein E1 in virus entry and assembly. Frontiers in Immunology 9 (JUN): 1–7. doi: 10.3389/fimmu.2018.01411.

Smith DB, Bukh J, Kuiken C et al. (2014) Expanded classification of Hepatitis C Virus into 7 genotypes and 67 subtypes: updated criteria and genotype as-signment web resource. Hepatology 59 (1): 318–327. doi:


Pawlotsky JM, Negro F, Aghemo A et al. (2020) EASL recommendations on treatment of hepatitis C: Final update of the series. Journal of Hepatology 73 (5): 1170–1218. doi: 10.1016/j.jhep.2020.08.018.

Rosenthal ES, Graham CS (2016) Price and afforda-bility of direct-acting antiviral regimens for hepatitis C virus in the United States. Infectious Agents and Cancer 11 (1): 1–8. doi: 10.1186/s13027-016-0071-z.

Khamthong N, Hutadilok-Towatana N (2017) Phyto-constituents and biological activities of Garcinia dul-cis (Clusiaceae): A Review. Natural Product Commu-nications 12 (3): 453–460. doi: 10.1177/1934578x1701200337.

Deachathai S, Mahabusarakam W, Phongpaichit S et al. (2005) Phenolic compounds from the flowers of Garcinia dulcis. Phytochemistry 67 (5): 464–469. doi: 10.1016/j.phytochem.2005.10.016.

Abu Bakar MF, Ahmad NE, Suleiman M et al. (2015) Garcinia dulcis Fruit extract induced cytotoxicity and apoptosis in HepG2 liver cancer cell line. BioMed Re-search International. doi: 10.1155/2015/916902

Tamhid HA (2019) Chemical compounds and antibacterial activity of Garcinia dulcis (Roxb)kurz. Indonesian Journal of Medicine and Health Journal 10: 71–85.

Annadya S (2016) antiviral activity of garcinia dulcis leaves extract against replication of dengue vi-rus serotype 2 in vitro on huh 7.5. Cell. Undergrad-uate thesis. Jakarta, Universitas Indonesia.

Chatel-chaix L, Bartenschlager R (2014) Den-gue Virus- and Hepatitis C virus-induced replication and assembly compartments: the enemy inside — caught in the web. Journal of Virology 88 (11): 5907–5911. doi: 10.1128/JVI.03404-13 Apriyanto DR, Aoki-Utsubo C, Hartati S et al. (2018) Potential of indonesian plants (annona mu-ricata, garcinia latissima, and garcinia celebica) against Hepatitis C Virus. Advanced Science Letters 24 (9): 6807–6810. doi: 10.1166/asl.2018.12850.

Aoki C, Hartati S, Santi M et al. (2014) Isolation and identification of substances with anti-hepatitis c virus activities from Kalanchoe pinnata. Internation-al Journal of Pharmacy and Pharmaceutical Sciences 6 (2): 211–215.

Apriyanto DR, Aoki C, Hartati S et al. (2016) Anti-hepatitis c virus activity of a crude extract from longan (Dimocarpus longan Lour.) leaves. Japanese Journal of Infectious Diseases 69 (3): 213–220. doi: 10.7883/yoken.JJID.2015.107.

Apriyanto DR, Hartati S, Dewi BE et al. (2019) In Vitro study of Garcinia celebica L. Stem Barks against Hepatitis C virus and Hepatocellular Carci-noma. Journal of Physics: Conference Series 1360 (012027): 1–4. doi:


Syajarwati P (2013) Uji aktivitas ekstrak kulit buah manggis (garcinia mangostana l .) sebagai in-hibitor RNA helikase Virus Hepatitis C. Undergradu-ate thesis. Jakarta, UIN Syarif Hidayatullah Jakarta

Choi M, Kim Y-M, Lee S et al. (2014) Mango-steen xanthones suppress hepatitis C virus genome replication. Virus Genes 49 (2): 208–222. doi: 10.1007/s11262-014-1098-0.

Wahyuni TS, Utsubo CA, Hotta H (2016) Prom-ising anti-hepatitis c virus compounds from natural resources. Natural Product Communications 11 (8): 1193–1200. doi: 10.1177/1934578x1601100840.

Saelee A, Phongpaichit S, Mahabusarakam W (2015) A new prenylated biflavonoid from the leaves of Garcinia dulcis. Natural Product Research 29 (20): 1884–1888. doi: 10.1080/14786419.2015.1010087.

Lin Y, Anderson H, Flavin MT et al. (1997) In Vitro anti-HIV activity of biflavonoids isolated from rhus succedanea and garcinia multiflora. Journal of natural products 3864 (97): 884–888.

Canard B, Figadère B, Guillemot J, Nour M (2012) Biflavonoids of Dacrydium balansae with Po-tent Inhibitory Activity on Dengue 2 NS5 Polymer-ase. Journal of Medicinal Plant and Natural Product Research 78 (12): 672–677.

Harrison L, Leong LS, Leong YW et al. (1994) Xanthone and flavonoid constituents of garcinia dul-cis (guttiferae). Natural Product Letters 5 (2): 111–116. doi: 10.1080/10575639408044043.

Sunil C, Duraipandiyan V, Ignacimuthu S, Al-Dhabi NA (2013) Antioxidant, free radical scaveng-ing and liver protective effects of friedelin isolated from Azima tetracantha Lam. leaves. Food Chemistry 139 (1–4): 860–865. doi: 10.1016/j.foodchem.2012.12.041.

Radi MH, El Shiekh RA, El Halawany AM, Ab-del Sattar E (2023) Friedelin and 3β-Friedelinol pharmacological activities. Revista Brasileira de Far-macognosia 33: 886–900.

Darshani P, Sen Sarma S, Srivastava AK et al. (2022) Anti-viral triterpenes: a review. Phytochem-istry Reviews 21 (6): 1761-1842. doi: 10.1007/s11101-022-09808-1.

Kar P, Sharma NR, Singh B et al. (2021) Natu-ral compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: An in silico investigation. Journal of Biomolecular Structure and Dynamics 39 (13): 4774–4785. doi: 10.1080/07391102.2020.1780947.

Chang FR, Yen CT, Ei-Shazly M et al. (2012) Anti-human coronavirus (anti-HCoV) triterpenoids from the leaves of Euphorbia neriifolia. Natural Product Communications 7 (11): 1415–1417. doi: 10.1177/1934578x1200701103.